Liposome Bupivacaine (Cosource Pharma)
布比卡因双羟萘酸盐脂质体（合源药业）
Report date: 2024/07/17 15:40:47
Base Information
Drug NameLiposome Bupivacaine (Cosource Pharma)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[4]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesHefei Cosource Pharmaceuticals
China Registration ClassN/A
Develop Information
Active CompaniesHefei Cosource Pharmaceuticals
Inactive CompaniesFruithy Medical Pty Ltd
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A